Related Experiment Video

Updated: Apr 29, 2026

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
05:06

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes

Published on: May 5, 2020

14.6K

hiPSC Modeling of Inherited Cardiomyopathies

Gwanghyun Jung1, Daniel Bernstein

  • 1Division of Cardiology, Department of Pediatrics, Stanford University, Stanford, CA, USA.

Current Treatment Options in Cardiovascular Medicine
|May 20, 2014
PubMed

Insights

Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) are valuable for studying inherited cardiomyopathies. While they model arrhythmias and other heart conditions, hiPSC-CMs exhibit immature phenotypes requiring further research for maturation.

Area of Science:

  • Cardiology
  • Stem Cell Biology
  • Genetics

Background:

  • Inherited cardiomyopathies are a significant cause of heart disease.
  • Human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) offer a promising in vitro model for studying these conditions.
  • Previous studies have successfully used hiPSC-CMs to model various inherited cardiac arrhythmias and cardiomyopathies.

Purpose of the Study:

  • To review the utility of hiPSC-CMs in modeling inherited cardiomyopathies.
  • To highlight the successes and limitations of hiPSC-CMs in disease modeling.
  • To discuss the need for further research into achieving mature hiPSC-CM phenotypes.

Main Methods:

  • Review of existing literature on hiPSC-CM applications in cardiomyopathy research.
  • Analysis of studies modeling inherited arrhythmias (Long QT, Timothy syndrome), arrhythmogenic right ventricular dysplasia (ARVD), dilated cardiomyopathy (DCM), and hypertrophic cardiomyopathy (HCM).

Main Results:

  • hiPSC-CMs have demonstrated success in modeling inherited arrhythmias and cardiomyopathies, providing novel insights into disease mechanisms.
  • A key limitation is that hiPSC-CMs do not fully replicate the structural and functional characteristics of mature adult cardiomyocytes, exhibiting an immature phenotype.
  • Despite limitations, hiPSC-CMs are currently the best in vitro model for the human heart.

Conclusions:

  • hiPSC-CMs are an invaluable tool for investigating the underlying mechanisms of cardiomyopathy.
  • Further research is essential to overcome the immaturity of hiPSC-CMs and enhance their translational value.
  • hiPSC-CMs are crucial for screening potential pharmacologic therapies for inherited heart conditions.
Abstract

More Related Videos

Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.08:37

Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.

Published on: March 3, 2021

3.8K
Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model03:45

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model

Published on: August 8, 2022

3.3K

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
804
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
821
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
753